Medical Device Design and Development Services Market – By Services, By Medical Devices, By Application, By End Use - Global Forecast, 2024 – 2032

Medical Device Design and Development Services Market Size

The global medical device design and development services market size was valued at around USD 10.4 billion in 2023 and is estimated to grow at 12.1% CAGR from 2024 to 2032. Medical device design and development services refer to a range of specialized offerings provided by companies or teams to create innovative medical devices, from initial concept to market-ready products. These services encompass the entire product development lifecycle, including conceptual design, prototyping, engineering, regulatory compliance, testing, and manufacturing scale-up.
 

The increasing demand for medical diagnostics and surgical interventions is a key driver of the market. This demand arises from factors such as the growing prevalence of chronic diseases, an aging population, and advancements in medical technology that offer new treatment options. As chronic conditions like cardiovascular disease, diabetes, and cancer become more widespread, the need for diagnostic tools and surgical interventions also rises. For example, according to the International Diabetes Federation (IDF), approximately 537 million adults (aged 20–79) were living with diabetes in 2021.
 

The IDF also projects that this number will increase to 643 million by 2030 and 783 million by 2045. This trend highlights the need for developing sophisticated medical devices, including diagnostic equipment and minimally invasive surgical instruments, which are essential for early detection, accurate diagnosis, and effective treatment of various medical conditions.
 

Additionally, rapid advancements in medical device technologies, rising investments in outsourcing medical device design and development, and the growing adoption of smart devices and connected medical care are further driving market growth.
 

Medical Device Design and Development Services Market Trends

• Rapid advancements in medical device technologies are significantly influencing the growth of the market. Innovations ranging from materials and manufacturing techniques to digital health solutions are transforming the healthcare landscape and driving demand for specialized development services.
   
• One major technological advancement is the miniaturization and integration of medical devices. As devices become smaller and more complex, they require sophisticated design and engineering services to ensure functionality, reliability, and user-friendliness. This trend is particularly evident in wearable medical devices, implantable sensors, and portable diagnostic tools, which are gaining popularity due to their convenience and ability to provide real-time data.
   
• For example, Medtronic’s Micra AV and Micra VR are types of transcatheter pacing systems (TPS) that represent the world’s smallest pacemaker. Similar to other recent transcatheter technologies, such as aortic or mitral valve replacement, these devices can be implanted using minimally invasive techniques and are positioned entirely within the heart.
   
• Another critical area of advancement is in materials science, including biocompatible and bioresorbable materials. These materials are essential for developing next-generation implants, prosthetics, and novel drug delivery systems. Design and development services must adapt to these new materials to optimize product performance, safety, and regulatory compliance.
   
• Furthermore, the rise of digital health and the Internet of Medical Things (IoMT) is also a significant driver. Connected devices, telemedicine, and health monitoring systems rely on advanced software and cybersecurity measures. The integration of artificial intelligence and machine learning in healthcare, particularly in diagnostics, treatment planning, and personalized medicine, requires specialized software development and data analytics capabilities.
   
• Thus, rapid technological advancements in medical devices are expanding the scope and complexity of the market.
   

Medical Device Design and Development Services Market Analysis

Based on services, the market is segmented into designing & engineering, machining, packaging, and moulding. The designing & engineering segment dominated the market accounting for the largest market revenue share of 37.4% in 2023 projecting its dominance with a CAGR of 12.4%.
 

• This This segment is the cornerstone of medical device innovation, encompassing critical phases such as conceptualization, prototyping, and detailed design. The initial stages of medical device creation are highly specialized and require extensive technical expertise to ensure that devices are not only functional but also compliant with stringent regulatory standards.
   
• Companies invest significantly in design and engineering services to develop devices that meet these high standards, making this segment a substantial part of the market.
   
• Additionally, the ongoing introduction of new and improved medical devices drives demand for design and engineering services. Companies aim to differentiate their products through advanced design and engineering, which contributes to the segment's growth.
   
• The effective integration of medical devices into existing healthcare systems and workflows requires meticulous design and engineering. This ensures that devices function seamlessly within clinical environments, further increasing demand for these services.
   

Based on medical devices, the medical device design and development services market is bifurcated into drug delivery devices, imaging devices, cardiovascular devices, POC diagnostic equipment, orthopedic devices, surgical devices, dental devices, sleep & respiratory devices, ophthalmology devices, endoscopy, diabetes care, neurostimulators, cochlear implants, and other medical devices. Further, drug delivery devices segment is segmented into infusion pumps, autoinjectors, prefilled syringes, inhalers, transdermal patches, nebulizers, nasal spray, intrauterine devices (IUDs). The drug delivery devices segment dominated the market with 13.3% of market share in 2023.
 

• The growing market for biologics and biosimilars, which often require specialized delivery systems, has driven demand for advanced drug delivery devices. These devices are essential for the administration of complex biologics, fueling growth in this segment.
   
• Drug delivery devices designed for ease of use enhance patient convenience and adherence to treatment protocols. Devices such as pre-filled syringes and transdermal patches simplify medication administration, improving compliance and, ultimately, health outcomes.
   
• Advances in pharmaceutical formulations, including long-acting injectables, nanoparticles, and liposomal formulations, require compatible and sophisticated drug delivery devices. These innovations necessitate the development of new delivery systems that can effectively administer advanced drug formulations.
   
• Furthermore, the shift towards patient-centric care models underscores the need for drug delivery devices that enhance patient experience and engagement.
   

Based on application, the medical device design and development services market is bifurcated into treatment and diagnostics. The treatment segment takes the lead in the market, capturing the largest market share of 63.2% in 2023 and is positioned to maintain its dominance throughout the forecast period, projected to achieve a CAGR of 12.7% during the analysis period.
 

• The treatment segment is driven by the increasing need for therapeutic solutions across a wide range of medical conditions. Advances in medical technology and the growing prevalence of chronic diseases necessitate innovative treatment options, contributing to the segment's significant market share and robust growth.
   
• For instance, according to the World Heart Report 2023, more than half a billion people worldwide continue to be affected by cardiovascular diseases, which were responsible for 20.5 million deaths in 2021.
   
• Ongoing advancements in treatment technologies, including new drug delivery systems, minimally invasive procedures, and advanced therapeutics, fuel the segment's growth. These innovations not only improve patient outcomes but also expand the range of available treatment options, further enhancing the segment’s market position.
   

Based on end use, the medical device design and development services market is bifurcated into medical device companies and biotechnology companies. The medical device companies segment dominated the market in 2023 with a market share of 87.8%.
 

• These companies often possess substantial financial resources, allowing them to invest heavily in the latest technologies, skilled workforces, and state-of-the-art facilities. This financial strength supports the development of cutting-edge medical devices and enhances their market competitiveness.
   
• Design and development service providers often have access to the latest technologies and tools, which medical device companies can leverage without significant capital investment. This access accelerates the development process and enhances product quality.
   
• The increasing number of medical device companies, rising demand for early diagnostics and better treatments, the growing prevalence of chronic diseases, and increasing healthcare expenditures further boost the growth of medical device companies in the market.
   

U.S. medical device design and development services market accounted for a 2.8 billion revenue in 2023 and is expected to experience substantial growth reaching USD 7.9 billion by 2032.
 

• The U.S. is at the forefront of technological innovation, particularly in fields such as artificial intelligence (AI), robotics, 3D printing, and biotechnology. These cutting-edge technologies are widely integrated into the design and development of medical devices, enabling the creation of more sophisticated, efficient, and personalized healthcare solutions.
   
• The U.S. medical device industry benefits from significant venture capital funding, government grants, and institutional investment. The country has robust financial backing for startups and established companies, facilitating the commercialization of new technologies.
   

The medical device design and development services market in the UK is projected to witness substantial growth, with a CAGR of 12.2% from 2024 to 2032.
 

• The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) provides a well-defined regulatory framework for medical devices. Post-Brexit, the UK has aligned much of its regulatory landscape with global standards while maintaining flexibility, allowing companies to navigate approvals with greater efficiency.
   
• The UK has a highly skilled workforce with expertise in engineering, life sciences, and clinical research. This expertise is critical in the design, prototyping, and testing phases of medical device development.
   

In 2023, Japan accounted for 19.1% revenue share in the Asia Pacific medical device design and development services market is anticipated to witness lucrative growth between 2024 and 2032.
 

• Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) works closely with the industry to ensure a streamlined approval process for new devices. The country’s harmonization with international regulatory standards, such as ISO certifications, facilitates global market entry for Japanese products.
   
• With one of the world's fastest-aging populations, Japan has developed expertise in medical devices aimed at elder care, such as assistive technologies, mobility aids, and home healthcare devices. This demographic focus drives demand for innovative solutions and enhances Japan’s position in geriatric healthcare technology.
   

The medical device design and development services market in Saudi Arabia is expected to growth with a CAGR of 11.1% from 2024 to 2032.
 

• Under Saudi Vision 2030, the government is heavily investing in healthcare infrastructure, including the medical device industry. This has led to increased funding for innovation, research, and development, attracting global and local companies to establish a presence in the kingdom.
   
• Additionally, Saudi Arabia has a rising demand for medical devices, particularly driven by an increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions. The need for innovative diagnostic and therapeutic devices provides significant market opportunities for companies involved in design and development, contributing to the market's steady growth.
   

Medical Device Design and Development Services Market Share

The market features a competitive landscape with major global players and small to medium-sized firms vying for market share. A key strategy within the industry centers on the continuous development of innovative technologies aimed at enhancing device functionality, safety, and regulatory compliance. Leading companies drive advancements by making substantial investments in research and development, focusing on refining design processes, improving prototyping techniques, and ultimately optimizing patient outcomes. Strategic alliances, partnerships, and collaborations are also crucial for strengthening market positions and expanding global reach, especially in response to evolving healthcare standards, the growing demand for personalized medical solutions, and the increasing emphasis on digital health technologies and minimally invasive devices.
 

Medical Device Design and Development Services Market Companies

Some of the eminent market participants operating in the medical device design and development services industry include:

• Celestica
• Cambridge Design Partnership
• Creation Technologies
• Cirtec Medical
• Donatelle
• Flex
• Integer Holdings Corporation
• Jabil
• Nordson Corporation
• Planet Innovation
• Plexus Corporation
• Quest Global
• Sanmina Corporation
• StarFish Product Engineering
• Veranex
   

Medical Device Design and Development Services Industry News:

• In January 2024, Creation Technologies launched its new, state-of-the-art facility in Newark, NY. This expansion reflects the company's strategic growth efforts to better address its customers' evolving needs.
   
• In April 2022, Integer Holdings Corporation acquired Connemara Biomedical Holdings, including Aran Biomedical and Proxy Biomedical. This acquisition bolstered Integer’s capabilities in implantable medical devices and enhancing its development and manufacturing expertise in the sector.
   

The medical device design and development services market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Services

• Designing & engineering
• Machining
• Packaging
• Moulding

Market, By Medical Devices

• Drug delivery devices
  • Autoinjectors
  • Infusion pumps       
  • Prefilled syringes
  • Inhalers        
  • Nebulizers
  • Nasal spray
  • Intrauterine devices (IUDs)
  • Transdermal patches 
• Cardiovascular devices
  • Ventricular assist devices
  • Total artificial hearts
  • Pacemakers
  • Implantable cardioverter defibrillators (ICDs)
  • Cardiac loop recorders
  • Holter monitors
  • Event monitors
  • ECMO systems
  • Consumables
• POC diagnostic equipment
  • Blood glucose monitor       
  • Blood analyzer        
  • Blood pressure monitor      
  • Pregnancy test kit
  • Infectious diseases testing
  • HbA1c testing
  • Coagulation testing kit
  • Cardiac markers test
  • Thyroid stimulating hormone test
  • Other POC diagnostic equipment
• Orthopedic devices
  • Prosthetics
  • Orthopedic navigation systems
  • Other orthopedic devices
• Dental devices
• Surgical devices
  • Surgical robots       
  • Other surgical devices
• Imaging devices
  • X-ray 
  • MRI scanners
  • Ultrasound
  • CT scanners
  • Nuclear imaging scanners
• Sleep & respiratory devices
  • Positive airway pressure (PAP) devices
  • Ventilators
  • Oxygen concentrators
  • Other sleep and respiratory devices
• Ophthalmology devices
  • Fundus cameras
  • Slit lamps
  • Optical coherence tomography
  • Corneal topography systems
  • Other ophthalmology devices
• Endoscopy    
• Diabetes care
• Cochlear implants    
• Neurostimulators
  • Spinal cord stimulators
  • Deep brain stimulators
  • Other neurostimulators
• Other medical devices

Market, By Application

• Treatment
• Diagnostics

Market, By End Use

• Medical device companies
• Biotechnology companies   

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America 
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE